Keywords

Alimentary Canal

Barium Swallows

Colorectal Cancer

Digestive Oncology

Endocrine Disorders

Endoscopy

Endoscopist-Directed Balanced Propofol Sedation During Endoscopic Retrograde Cholangiopancreatography: Safety And Efficacy

Authors:

William Stolarek

University in Madison, Wisconsin, US

Correspondence to Author:  William Stolarek

Abstract:

Background: Endoscopist-directed balanced propofol sedation (BPS) seems to be safe and effective for routine examination. However, there square measure restricted information on its use in scrutiny retrograde cholangiopancreatography (ERCP). Methods: This was a retrospective cohort study, mistreatment prospectively collected examination information from a tertiary care eye wherever endoscopist-directed rate throughout ERCP is routine apply. Adverse outcomes enclosed want for bag-mask ventilation or cannulization, aborted ERCP because of sedation, hospital admission post-ERCP (outpatients)/change within the level of care (inpatients), and death inside twenty four h. Results: a complete of 501 patients underwent ERCP with the utilization of endoscopist-directed BPS: Cohort one – 380 (76%) inpatients, mean age sixty four.1, 46% male, pure gold yankee Society of Anesthesiologists physical standing (ASA) score I, 65% ASA II, Martinmas ASA III. at the same time, twenty four patients received anesthesiologist-administered moderate sedation: Cohort a pair of – nineteen (79%) inpatients, mean age sixty five.0, 67% male, 12% ASA I, 25% ASA II, thirty eighth ASA III, 25% ASA IV. In Cohort one, none of the adverse outcomes were discovered. Propofol dose was reciprocally related with age (r=-0.42, P.


Keywords:
Propofol, endoscopic retrograde cholangiopancreatography, balanced propofol sedation, endoscopy, anesthesiology, moderate sedation.

Citation:

William Stolarek. Endoscopist-directed balanced propofol sedation during endoscopic retrograde cholangiopancreatography: safety and efficacy Japanese Journal of Gastroenterology 2022.

Journal Info

  • Journal Name: Japanese Journal of Gastroenterology
  • Impact Factor: 2.709**
  • ISSN: 2832-4870
  • DOI: 10.52338/jjogastro
  • Short Name: JJOGASTRO
  • Acceptance rate: 55%
  • Volume: 4 (2024)
  • Submission to acceptance: 25 days
  • Acceptance to publication: 10 days

INDEXING

  • Crossref indexed journal
  • Publons indexed journal
  • Pubmed-indexed journal
  • International Scientific Indexing (ISI)-indexed journal
  • Eurasian Scientific Journal Index (ESJI) index journal
  • Semantic Scholar indexed journal
  • Cosmos indexed journal

OUR PUBLICATION BENEFITS

  • International Reach
  • Peer Review
  • Rapid Publication
  • Open Access
  • High Visibility